Delivery Order SPE2DB22D1106-SPE2DB24FEAS4
Award Date 2/16/24
Potential Completion Date 2/20/24
Potential Value $82K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,248,437 doxycycline 50 mg tablets. The contract, valued at $16,543.56, has an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp is the prime contractor and will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania. This delivery order is placed under an...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,458,511 units of 50 mg doxycycline tablets. The contract has a potential value of $19,696.08 and a period of performance through January 29, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this delivery order, which is not associated with any larger contract vehicle. The...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,074,952 units of Doxycycline Hyclate 100mg tablets. The $2,209.34 firm fixed-price contract has a period of performance through February 28, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order valued at $22,645.83 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 1,000 units of doxycycline hyclate 100 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
- This is a $6,810.66 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,731,511 units of doxycycline 50 mg tablets. The contract has an ultimate completion date of July 9, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,801.49 contract is for the delivery of 4,564,881 units of 100 mg doxycycline hyclate tablets. The order is part of AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,842,809 units of Doxycycline Hyclate 100 mg tablets, with a ceiling value of $1,093.88. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds...
- The Defense Logistics Agency awarded a delivery order valued at $10,374.00 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets (300 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,402.20. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through open competition. The order is scheduled for ultimate completion by June 20, 2025, and will be performed at AmerisourceBergen's corporate office...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $1,952.44 contract is for the delivery of 4,564,204,079 units of doxycycline hyclate 100mg tablets. The contract has an ultimate completion date of April 9, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEAS4Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,793,437 tablets of 100mg doxycycline hyclate with a completion date of February 20, 2024. The $82,355.00 contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger $999,999,999.00 indefinite delivery contract the company holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide in support of the Department of Defense.
Generated 5/17/24, 11:02 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $82.4k | 2/16/24 |